← Open Payments lookup

LARISSA GONZALEZ: Open Payments

NPI 1811461106 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,026 in 134 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $2,969 · 2025 $3,026

Food & beverage: $3,026
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc13$524
ABBVIE INC.22$501
Otsuka America Pharmaceutical, Inc.13$301
Vanda Pharmaceuticals Inc.14$287
Neurocrine BioSciences, Inc.8$268
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$266
Alkermes, Inc.11$251
Lundbeck LLC11$167
Teva Pharmaceuticals USA, Inc.9$138
Axsome Therapeutics, Inc.4$109

Products named: VRAYLAR, SPRAVATO, REXULTI, FANAPT, INGREZZA, CAPLYTA, ARISTADA, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.